EUVIMEDEUVIMED entdecken
Crossref

Pterostilbene exerts anti‐lung squamous cell carcinoma function by suppressing the level of KANK3

Hua He, Tian Li

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14597 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Hua He und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China. Hauptthemen laut MEDLINE: Stilbenes, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early detection of lung squamous cell carcinoma (LUSC) has a significant impact on clinical outcomes, and pterostilbene (PT) is a natural compound with promising anti‐oncogenic activities. This study aimed to identify potential LUSC biomarkers through a series of bioinformatic analyses and clinical verification and explored the interaction between PT and selected biomarkers during the treatment of LUSC. The analysis of the expression profile of the clinical samples of LUSC was performed to identify dysexpressed genes (DEGs) and validated by IHC. The role of KANK3 in the anti‐LUSC effects of PT was assessed with a series of in vitro and in vivo assays. 4335 DEGs were identified, including 1851 upregulated genes and 2484 downregulated genes. Survival analysis showed that KANK3 was significantly higher in patients with LUSC with an advanced tumor stage. In in vitro assays, PT suppressed cell viability, induced apoptosis, and inhibited migration and invasion in LUSC cell lines, which was associated with downregulation of KANK3. After the reinduction of the KANK3 level in LUSC cells, the anti‐LUSC function of PT was impaired. In mice model, reinduction of KANK3 increased tumor growth and metastasis even under the treatment of PT. The findings outlined in the current study indicated that PT exerted anti‐LUSC function in a KANK3 inhibition‐dependent manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StilbenesLung NeoplasmsCarcinoma, Squamous CellHumansAnimalsMiceCell Line, TumorApoptosisCell MovementMice, NudeAdaptor Proteins, Signal TransducingMaleFemaleMice, Inbred BALB CAntineoplastic AgentsCell SurvivalCytoskeletal ProteinsDown-RegulationGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

KANK3TCGAlung squamous cell carcinomapterostilbene

Substanzen

pterostilbeneStilbenesAdaptor Proteins, Signal TransducingAntineoplastic AgentsCytoskeletal Proteins

Autor:innen und Institutionen

  • Department of Respiratory, Nanjing Chest Hospital, Affiliated Nanjing Brain Hospital, Nanjing Medical University, Nanjing, China.

Zitieren

APA

He, H., & Li, T. (2024). Pterostilbene exerts anti‐lung squamous cell carcinoma function by suppressing the level of KANK3. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14597

Vancouver

He H, Li T. Pterostilbene exerts anti‐lung squamous cell carcinoma function by suppressing the level of KANK3. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14597

BibTeX
@article{He2024,
  author = {He, Hua and Li, Tian},
  title = {Pterostilbene exerts anti‐lung squamous cell carcinoma function by suppressing the level of KANK3},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14597}
}
Kostenlos starten →